SCHEMBL23809489

SCHEMBL23809489

COCc1cc(C(C)C)c2c(c1)cc(C(=O)O)n2C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 3/20 0.46
SRD5A2 P31213 2/20 0.39
SRD5A1 P18405 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MCL1 Q07820 3/20 0.36
GPR35 Q9HC97 1/20 0.36
PHGDH O43175 1/20 0.34
GAA P10253 1/20 0.33
KDM1A O60341 1/20 0.33
MAOB P27338 1/20 0.33
RCOR1 Q9UKL0 1/20 0.33
MAPK1 P28482 1/20 0.33
GFER P55789 2/20 0.32
THRA P10827 2/20 0.32
THRB P10828 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809282 0.90 ALDH1A1 (0.42) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809517 0.83 ALDH1A1 (0.38) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809153 0.81 HSD17B10 (0.36) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809290 0.80 KDM4E (0.54) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809132 0.79 MCL1 (0.39) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809314 0.79 KDM4E (0.41) ALDH1A1KDM4ELMNAMAPK1KMT2A
SCHEMBL23809170 0.79 HSD17B10 (0.47) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809525 0.79 HRH3 (0.41) HSD17B10ALDH1A1KDM4EHPGDMAPK1
SCHEMBL23809228 0.79 KDM4E (0.43) HSD17B10ALDH1A1KDM4EHPGDSRD5A2
SCHEMBL23809313 0.77 HSD17B10 (0.46) HSD17B10ALDH1A1KDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 HSD17B10 3627/4885ALDH1A1 2556/4885KDM4E 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.